Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma

BACKGROUND: Immune checkpoint inhibitors have improved clinical outcomes including survival in several malignancies but have also been associated with a range of immune-related adverse events (irAEs). Neurological irAEs are rare compared to the more typical skin, gastrointestinal, and endocrine toxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Catherine A., Weber, Urs M., Peixoto, Aldo J., Weiss, Sarah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796437/
https://www.ncbi.nlm.nih.gov/pubmed/31623673
http://dx.doi.org/10.1186/s40425-019-0748-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796437/
https://www.ncbi.nlm.nih.gov/pubmed/31623673
http://dx.doi.org/10.1186/s40425-019-0748-0

Ejemplares similares